0001104659-26-077366 | 11-K | XBRL Viewer

Schedule of fair value hierarchy levels of the Plan's assets

The following tables set forth the fair value hierarchy levels of the Plan’s assets at fair value at December 31, (dollars in thousands):


	Basis of Fair Value Measurement
2025	Level 1		Level 2		Level 3		Total
Interest bearing cash	$	25	$	—	$	—	$	25
Common stock		3,047,016		—		—		3,047,016
Mutual funds		5,288		—		—		5,288
Collective trust funds		12,461,950		—		—		12,461,950
Self-directed brokerage accounts		204,031		—		—		204,031
Total assets at fair value	$	15,718,310	$	—	$	—	$	15,718,310


	Basis of Fair Value Measurement
2024	Level 1		Level 2		Level 3		Total
Interest bearing cash	$	93	$	—	$	—	$	93
Common stock		2,583,223		—		—		2,583,223
Mutual funds		3,255		—		—		3,255
Collective trust funds		10,447,456		—		—		10,447,456
Self-directed brokerage accounts		149,210		—		—		149,210
Total assets at fair value	$	13,183,237	$	—	$	—	$	13,183,237

Schedule of fair value hierarchy levels of the Plan's assets

The following tables set forth the fair value hierarchy levels of the Plan’s assets at fair value at December 31, (dollars in thousands):


	Basis of Fair Value Measurement
2025	Level 1		Level 2		Level 3		Total
Common stock	$	329,280		—		—	$	329,280
Mutual funds		8,595		—		—		8,595
Collective trust funds		325,555		—		—		325,555
Self-directed brokerage accounts		1,850		—		—		1,850
Total assets at fair value	$	665,280	$	—	$	—	$	665,280


	Basis of Fair Value Measurement
2024	Level 1		Level 2		Level 3		Total
Common stock	$	276,713		—		—	$	276,713
Mutual funds		41,065		—		—		41,065
Collective trust funds		233,155		—		—		233,155
Self-directed brokerage accounts		1,571		—		—		1,571
Total assets at fair value	$	552,504	$	—	$	—	$	552,504

- Definition

Tabular disclosure of fair value of investment held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)), including, but not limited to, fair value measured at net asset value per share as practical expedient (NAV).

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-3

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 962
-SubTopic 325
-Name Accounting Standards Codification
-Section 45
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477509/962-325-45-5

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 962
-SubTopic 325
-Name Accounting Standards Codification
-Section 55
-Paragraph 17
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478873/962-325-55-17

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 962
-SubTopic 325
-Name Accounting Standards Codification
-Section 45
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477509/962-325-45-6

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 962
-SubTopic 325
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477783/962-325-50-3

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-8

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-3

+ Details

RELATED-PARTY AND PARTY-IN-INTEREST TRANSACTIONS (Details) - AbbVie common shares - AbbVie $ in Millions	12 Months Ended
Dec. 31, 2025 USD ($)
AbbVie Savings Plan
RELATED-PARTY AND PARTY-IN-INTEREST TRANSACTIONS
Common stock dividend received	$ 79.0
AbbVie Puerto Rico Savings Plan
RELATED-PARTY AND PARTY-IN-INTEREST TRANSACTIONS
Common stock dividend received	$ 8.3

SUBSEQUENT EVENTS	12 Months Ended
Dec. 31, 2025
AbbVie Savings Plan
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE G – SUBSEQUENT EVENTS AbbVie has evaluated subsequent events and there were no subsequent events that require recognition or additional disclosure in these financial statements.
AbbVie Puerto Rico Savings Plan
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE G – SUBSEQUENT EVENTS The Company has evaluated subsequent events and there were no subsequent events that require recognition or additional disclosure in these financial statements.

INVESTMENTS (Details) - USD ($) $ / shares in Units, $ in Thousands	Dec. 31, 2025	Dec. 31, 2024
AbbVie Savings Plan
INVESTMENTS
Investments, at fair value	$ 15,718,310	$ 13,183,237
AbbVie Savings Plan \| AbbVie common shares \| AbbVie
INVESTMENTS
Common Shares	11,638,215	12,340,181
Investments, at fair value	$ 2,659,216	$ 2,192,850
Market value per share	$ 228.49	$ 177.7
AbbVie Puerto Rico Savings Plan
INVESTMENTS
Investments, at fair value	$ 665,280	$ 552,504
AbbVie Puerto Rico Savings Plan \| AbbVie common shares \| AbbVie
INVESTMENTS
Common Shares	1,228,784	1,290,504
Investments, at fair value	$ 280,765	$ 229,322
Market value per share	$ 228.49	$ 177.7

- Definition

Fair value of investment, excluding plan interest in master trust, held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Includes, but is not limited to, derivative, investment measured at net asset value per share as practical expedient, and insurance contract not meeting fully-benefit responsive investment criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4B
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4A
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-3

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-3

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 962
-SubTopic 325
-Name Accounting Standards Codification
-Section 55
-Paragraph 17
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478873/962-325-55-17

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Topic 962
-SubTopic 325
-Name Accounting Standards Codification
-Section 45
-Paragraph 5
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477509/962-325-45-5

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4K
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4K

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Topic 962
-SubTopic 325
-Name Accounting Standards Codification
-Section 45
-Paragraph 5
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477509/962-325-45-5

Reference 12: http://www.xbrl.org/2003/role/exampleRef
-Topic 962
-SubTopic 325
-Name Accounting Standards Codification
-Section 45
-Paragraph 5
-Subparagraph (j)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477509/962-325-45-5

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-7A

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6A
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 962
-SubTopic 325
-Name Accounting Standards Codification
-Section 45
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477509/962-325-45-5

Reference 16: http://www.xbrl.org/2003/role/exampleRef
-Topic 962
-SubTopic 325
-Name Accounting Standards Codification
-Section 45
-Paragraph 5
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477509/962-325-45-5

Reference 17: http://www.xbrl.org/2003/role/exampleRef
-Topic 962
-SubTopic 325
-Name Accounting Standards Codification
-Section 45
-Paragraph 5
-Subparagraph (k)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477509/962-325-45-5

Reference 18: http://www.xbrl.org/2003/role/exampleRef
-Topic 962
-SubTopic 325
-Name Accounting Standards Codification
-Section 45
-Paragraph 5
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477509/962-325-45-5

Reference 19: http://www.xbrl.org/2003/role/exampleRef
-Topic 962
-SubTopic 325
-Name Accounting Standards Codification
-Section 45
-Paragraph 5
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477509/962-325-45-5

Reference 20: http://www.xbrl.org/2003/role/exampleRef
-Topic 962
-SubTopic 325
-Name Accounting Standards Codification
-Section 45
-Paragraph 5
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477509/962-325-45-5

Reference 21: http://www.xbrl.org/2003/role/exampleRef
-Topic 962
-SubTopic 325
-Name Accounting Standards Codification
-Section 45
-Paragraph 5
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477509/962-325-45-5

Reference 22: http://www.xbrl.org/2003/role/exampleRef
-Topic 962
-SubTopic 325
-Name Accounting Standards Codification
-Section 45
-Paragraph 5
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477509/962-325-45-5

+ Details

DESCRIPTION OF THE PLAN - Contributions and Vesting (Details)	12 Months Ended
	Dec. 31, 2025 USD ($) Y company shares	Dec. 31, 2024 USD ($)
AbbVie Savings Plan
DESCRIPTION OF THE PLAN
Number of publicly traded companies \| company	2
Exchange ratio \| shares	1
Dividend distribution period	90 days
Number of consecutive break years \| Y	5
Severance period	12 months
Forfeitures reduced employer contribution	$ 4,100,000
Forfeitures available	$ 3,600,000	$ 1,800,000
AbbVie Savings Plan \| Employees Not Covered Under ASP Plus
DESCRIPTION OF THE PLAN
Employee contribution	2.00%
Employer matching contribution	5.00%
AbbVie Savings Plan \| Employees Covered Under ASP Plus
DESCRIPTION OF THE PLAN
Automatic contributions	3.00%
Employer matching contribution	6.00%
AbbVie Savings Plan \| Minimum \| Employees Not Covered Under ASP Plus
DESCRIPTION OF THE PLAN
Employee contribution	2.00%
AbbVie Savings Plan \| Minimum \| Employees Covered Under ASP Plus
DESCRIPTION OF THE PLAN
Employee contribution	1.00%
AbbVie Savings Plan \| Maximum \| Employees Not Covered Under ASP Plus
DESCRIPTION OF THE PLAN
Employee contribution	50.00%
AbbVie Savings Plan \| Maximum \| Employees Covered Under ASP Plus
DESCRIPTION OF THE PLAN
Employee contribution	50.00%
AbbVie Puerto Rico Savings Plan
DESCRIPTION OF THE PLAN
Number of publicly traded companies \| company	2
Exchange ratio \| shares	1
Number of consecutive break years \| Y	5
Severance period	12 months
Forfeitures reduced employer contribution	$ 41,000
Forfeitures available	$ 76,400	$ 34,600
AbbVie Puerto Rico Savings Plan \| Employees Not Covered Under ASP Plus
DESCRIPTION OF THE PLAN
Employee contribution	2.00%
Employer matching contribution	5.00%
AbbVie Puerto Rico Savings Plan \| Employees Covered Under ASP Plus
DESCRIPTION OF THE PLAN
Automatic contributions	3.00%
Employer matching contribution	6.00%
AbbVie Puerto Rico Savings Plan \| Minimum \| Employees Not Covered Under ASP Plus
DESCRIPTION OF THE PLAN
Employee contribution	2.00%
AbbVie Puerto Rico Savings Plan \| Minimum \| Employees Covered Under ASP Plus
DESCRIPTION OF THE PLAN
Employee contribution	1.00%
AbbVie Puerto Rico Savings Plan \| Maximum \| Employees Not Covered Under ASP Plus
DESCRIPTION OF THE PLAN
Employee contribution	50.00%
AbbVie Puerto Rico Savings Plan \| Maximum \| Employees Covered Under ASP Plus
DESCRIPTION OF THE PLAN
Employee contribution	50.00%

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

12 Months Ended

Dec. 31, 2025

Notes Receivable from Participants

Basis of Accounting

The financial statements have been prepared using the accrual basis of accounting.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and changes therein, and disclosure of contingent assets and liabilities. Actual results may differ from those estimates.

Investment Valuation

Investments are reported at fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Plan uses the following methods and significant assumptions to estimate the fair value of investments:

Interest bearing cash - Valued at its holding amount.

Common stock, mutual funds and collective trust funds - Valued at the published net asset value (“NAV”) or market price per share.

Self-directed brokerage accounts – Include various securities, mainly consisting of cash and cash equivalents, common stock, exchange-traded funds, and mutual funds, which are valued at the closing price reported in the active market in which the securities are traded.

The fair value hierarchy under the accounting standard for fair value measurements consists of the following three levels:

●

Level 1 – Valuations based on unadjusted quoted prices in active markets for identical assets that the Plan has the ability to access;

●

Level 2 – Valuations based on quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuations in which all significant inputs are observable in the market; and

●

Level 3 – Valuations using significant inputs that are unobservable in the market and include the use of judgment by the company’s management about the assumptions market participants would use in pricing the asset or liability.

The following tables set forth the fair value hierarchy levels of the Plan’s assets at fair value at December 31, (dollars in thousands):


	Basis of Fair Value Measurement
2025	Level 1		Level 2		Level 3		Total
Interest bearing cash	$	25	$	—	$	—	$	25
Common stock		3,047,016		—		—		3,047,016
Mutual funds		5,288		—		—		5,288
Collective trust funds		12,461,950		—		—		12,461,950
Self-directed brokerage accounts		204,031		—		—		204,031
Total assets at fair value	$	15,718,310	$	—	$	—	$	15,718,310


	Basis of Fair Value Measurement
2024	Level 1		Level 2		Level 3		Total
Interest bearing cash	$	93	$	—	$	—	$	93
Common stock		2,583,223		—		—		2,583,223
Mutual funds		3,255		—		—		3,255
Collective trust funds		10,447,456		—		—		10,447,456
Self-directed brokerage accounts		149,210		—		—		149,210
Total assets at fair value	$	13,183,237	$	—	$	—	$	13,183,237

Notes receivable from participants are measured at their unpaid balance plus any accrued but unpaid interest. Delinquent loans are reclassified as distributions based upon the terms of the Plan. No allowance for credit losses has been recorded as of December 31, 2025 and 2024.

Investment Income Recognition

Purchases and sales of securities are recorded on a trade-date basis. Interest income is recorded on an accrual basis. Dividends are recorded on the ex-dividend date. Net realized and unrealized appreciation/depreciation is recorded in the accompanying statement of changes in net assets available for benefits as net appreciation in fair value of investments.

Payment of Benefits

Benefits are recorded when paid.

Notes Receivable from Participants

Basis of Accounting

The financial statements have been prepared using the accrual basis of accounting.

Use of Estimates

Investment Valuation

Common stock, mutual funds and collective trust funds - Valued at the published net asset value (“NAV”) or market price per share.

Self-directed brokerage accounts – Include various securities, mainly consisting of cash and cash equivalents, common stock, and exchange-traded funds, which are valued at the closing price reported in the active market in which the securities are traded.

The fair value hierarchy under the accounting standard for fair value measurements consists of the following three levels:

●

Level 1 – Valuations based on unadjusted quoted prices in active markets for identical assets that the Plan has the ability to access;

●

The following tables set forth the fair value hierarchy levels of the Plan’s assets at fair value at December 31, (dollars in thousands):


	Basis of Fair Value Measurement
2025	Level 1		Level 2		Level 3		Total
Common stock	$	329,280		—		—	$	329,280
Mutual funds		8,595		—		—		8,595
Collective trust funds		325,555		—		—		325,555
Self-directed brokerage accounts		1,850		—		—		1,850
Total assets at fair value	$	665,280	$	—	$	—	$	665,280


	Basis of Fair Value Measurement
2024	Level 1		Level 2		Level 3		Total
Common stock	$	276,713		—		—	$	276,713
Mutual funds		41,065		—		—		41,065
Collective trust funds		233,155		—		—		233,155
Self-directed brokerage accounts		1,571		—		—		1,571
Total assets at fair value	$	552,504	$	—	$	—	$	552,504

Investment Income Recognition

Payment of Benefits

Benefits are recorded when paid.

- Definition

Disclosure of accounting policy for use of estimate in preparation of financial statement of employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).

+ References + Details

STATEMENTS OF NET ASSETS AVAILABLE FOR BENEFITS - USD ($) $ in Thousands	Dec. 31, 2025	Dec. 31, 2024
AbbVie Savings Plan
Assets
Investments, at fair value	$ 15,718,310	$ 13,183,237
Employer contributions receivable	152,317	128,764
Notes receivable from participants	81,721	76,683
Transactions pending investment		229
Total assets	15,952,348	13,388,913
Liabilities
Accrued investment management fees	109	104
Transactions pending redemption	310	999
Total liabilities	419	1,103
NET ASSETS AVAILABLE FOR BENEFITS	15,951,929	13,387,810
AbbVie Puerto Rico Savings Plan
Assets
Cash	3	56
Investments, at fair value	665,280	552,504
Employer contributions receivable	1,773	1,345
Notes receivable from participants	7,771	6,230
Liabilities
NET ASSETS AVAILABLE FOR BENEFITS	$ 674,827	$ 560,135

DESCRIPTION OF THE PLAN

12 Months Ended

Dec. 31, 2025

DESCRIPTION OF THE PLAN

NOTE A - DESCRIPTION OF THE PLAN

The following description of the AbbVie Savings Plan (the “Plan”) provides only general information. Participants should refer to the Plan document for a more complete description of the Plan’s provisions.

General

In general, United States employees of AbbVie Inc. (“AbbVie”) and selected participating subsidiaries and affiliates may, after their date of hire, voluntarily participate in the Plan. Any eligible employee who begins employment or re-employment on or after January 1, 2022, and any eligible employee who first becomes eligible to participate in the Plan on or after January 1, 2022, shall be covered by the AbbVie Savings Plan Plus (“ASP+”) provisions set forth in the Plan document. The ASP+ provisions provide for automatic enrollment into the Plan and matching contribution and annual company contribution formulas that differ from those that apply to participants who joined the Plan before January 1, 2022. The Plan is subject to the provisions of the Employee Retirement Income Security Act of 1974 (“ERISA”), as amended.

Empower Retirement serves as the recordkeeper and Empower Trust Company, LLC (“Trustee”) serves as the custodian and trustee.

Mergers

Effective February 12, 2024, ImmunoGen, Inc. became a wholly owned subsidiary of AbbVie. On March 3, 2025, the ImmunoGen, Inc. 401(k) Plan and Trust merged into the Plan and net assets totaling approximately $62.6 million were transferred into the Plan.

Effective August 1, 2024, Cerevel Therapeutics, LLC became a wholly owned subsidiary of AbbVie. On March 3, 2025, the Cerevel Therapeutics, LLC 401(k) Plan merged into the Plan and net assets totaling approximately $41.4 million were transferred into the Plan.

Effective January 23, 2025, Nimble Therapeutics, Inc. became a wholly owned subsidiary of AbbVie. On December 4, 2025, the Nimble Therapeutics, Inc. 401(k) Plan merged into the Plan and net assets totaling approximately $3.0 million were transferred into the Plan.

Contributions and Vesting

Contributions to the Plan are paid to the AbbVie Savings Plan Trust (“Trust”). The Trust is administered by the Trustee and an investment committee comprised of AbbVie employees (the “Committee”).

Eligible employees electing to participate may choose to make their contributions from pre-tax earnings, after-tax earnings or both. The Plan permits Roth 401(k) after-tax contributions and a Roth 401(k) conversion feature. Participants who have attained age 50 before the end of the Plan year and who are making the maximum pre-tax or Roth contributions are eligible to make catch-up contributions. The pre-tax contributions are an elective deferral feature, which is a cash or deferred arrangement under the provisions of Section 401(k) of the Internal Revenue Code (“IRC”). All the contributions are subject to certain limitations of the IRC. Participant contributions may be invested in any of the investment options offered by the Plan.

NOTE A - DESCRIPTION OF THE PLAN – Continued

Contributions and Vesting - Continued

Eligible employees who are not covered by ASP+ and who elect to participate in the Plan may contribute from 2% to 50% of their eligible earnings to the Trust. Eligible employees covered by ASP+ and who elect to participate in the Plan may contribute from 1% to 50% of their eligible earnings to the Trust. Following the 30-day period from an employee’s hire or eligibility date, employees covered by ASP+ who have not affirmatively enrolled in the Plan and elected a specified contribution type and percentage or who have not opted out of automatic contributions, will be automatically enrolled in the Plan to contribute 3% of their pre-tax earnings.

Employer matching contributions to the Plan are made each payroll period based on the participating employees’ eligible earnings. Catch-up contributions are not eligible for matching contributions. The amount of the employer matching contribution for participants not covered by ASP+ is determined by the Board of Directors of AbbVie and, for the year ended December 31, 2025, was 5% of the participant’s eligible earnings if the employee elected to contribute at least 2% to the Plan. For participants covered by ASP+, contributions are matched dollar for dollar up to 6% of the participant’s eligible earnings.

In addition, ASP+ participants receive an annual employer contribution if the ASP+ participant is employed by AbbVie on the last day of the Plan year or separated from employment during the Plan year due to death or qualifying retirement. The annual employer contribution is equal to a percentage of eligible compensation based on each eligible ASP+ participant’s age plus years of credited service according to the following schedule:


Age + Years of Credited Service (whole years)	Contribution Percentage
Less than 30	2	%
30-39	3	%
40-49	4	%
50-59	5	%
60-69	6	%
70 or more	7	%

Employer contributions are invested according to the employee’s investment elections.

The Plan offers a variety of investment options, including AbbVie common shares. AbbVie was established by the January 1, 2013 separation of Abbott Laboratories (“Abbott”) into two publicly traded companies. The separation was a tax-free distribution where Abbott shareholders received one share of AbbVie stock for every share of Abbott held as of the close of business on December 12, 2012, the record date for the distribution. Effective January 1, 2013, AbbVie participants may no longer make new contributions or transfer funds to purchase Abbott stock in the Plan; however, they may continue to hold Abbott stock in their Plan accounts.

Cash dividends on shares of AbbVie common shares are (1) paid in cash to the participants or beneficiaries, (2) paid to the Plan and distributed in cash to participants or beneficiaries no later than 90 days after the close of the Plan year in which paid or (3) paid to the Plan and credited to the applicable accounts in which shares are held, as elected by each participant or beneficiary in accordance with rules established by the Plan administrator.

NOTE A - DESCRIPTION OF THE PLAN - Continued

Contributions and Vesting - Continued

Participants are at all times fully vested in their own contributions and earnings thereon. Vesting in employer matching contributions is based on the following vesting schedule:


	Vesting
Years of Credited Service	Percentage
Less than 2 years	0	%
2 years or more	100	%

Vesting in the annual employer contribution for ASP+ participants is based on the following vesting schedule:


	Vested
Years of Credited Service	Percentage
Less than 1	0	%
1	20	%
2	40	%
3	60	%
4	80	%
5 or more	100	%

Non-vested portions of employer contributions and earnings thereon are forfeited upon the earlier of (a) the date of distribution of the vested portion of the participant’s full balance or (b) the date on which the participant incurs five consecutive “break years” (i.e., a 12-consecutive month period of severance). Forfeitures are used to (1) restore any forfeitures of participants who are reemployed with AbbVie before incurring five consecutive break years, (2) fund corrective allocations or contributions and/or (3) reduce future employer contributions. In 2025, forfeitures reduced AbbVie’s employer contributions by approximately $4.1 million. Approximately $3.6 million and $1.8 million of forfeitures were available at the end of 2025 and 2024, respectively.

Distributions

Following retirement, termination or death, participants or their beneficiaries receive distributions in cash and/or AbbVie common shares and may receive them in installments, lump sums or direct rollovers, as applicable. Also, participants may elect to defer distribution to a future date but, after termination of employment, distribution must be made or commence by the 1^st of April following the year the participant reaches age 73. When participants defer distributions, their account balance remains in the Plan, and they may continue to transfer funds among the Plan’s investment options. In-service withdrawals are available in certain circumstances as defined by the Plan. The Plan also permits hardship withdrawals for participants who meet the criteria outlined in the Plan document.

NOTE A - DESCRIPTION OF THE PLAN - Continued

Administrative Expenses

Investment fees for mutual funds and collective trusts are charged against the net assets of the respective fund. All other expenses incident to the administration of the Plan and Trust are charged to the Trust, except to the extent AbbVie pays such expenses directly. Expenses paid by AbbVie are excluded from these financial statements. To the extent that any expense is specifically attributable to a participant’s account (including, but not limited to, a managed account service fee, loan fee, Qualified Domestic Relations Order review fee, brokerage fee, or check fee), such expense is charged to the account of the participant.

Participant Accounts

Each participant’s account is credited with the participant’s contributions and employer contributions and allocations of plan earnings and charged with any participant account fees. Plan earnings are allocated based on the participant’s share of net earnings or losses of their respective elected investment options. The benefit to which a participant is entitled is the benefit that can be provided from the participant’s vested account.

Notes Receivable from Participants

Participants may borrow from their accounts a minimum of $1,000 up to a maximum equal to the lesser of $50,000 or 50% of their vested account balance, subject to IRC limitations and restrictions and Plan rules, and may have one or two loans outstanding. The loans are secured by the balance in the participant’s account. Participants pay interest on such loans at the prime rate on the first business day of the month the loan is made. Loans must be repaid within five years unless the loan is used for the purchase of the primary residence of the employee, in which case the repayment period can be extended to a period of fifteen years. Repayment is made through periodic payroll deductions, but a loan may be repaid in a lump sum at any time. For employees terminating employment with AbbVie during the repayment period who do not repay their loan before distribution of their Plan account, the balance of the outstanding loan is netted from their Plan distribution.

DESCRIPTION OF THE PLAN

NOTE A - DESCRIPTION OF THE PLAN

The following description of the AbbVie Puerto Rico Savings Plan (the “Plan”) provides only general information. Participants should refer to the Plan document for a more complete description of the Plan’s provisions.

General

In general, employees of AbbVie Inc.’s (“AbbVie”) selected subsidiaries and affiliates in Puerto Rico (the “Company”) may, after their date of hire, voluntarily participate in the Plan. Any eligible employee who begins employment or re-employment on or after January 1, 2022, and any eligible employee who first becomes eligible to participate in the Plan on or after January 1, 2022, shall be covered by the AbbVie Puerto Rico Savings Plan Plus (“ASP+”) provisions set forth in the Plan document. The ASP+ provisions provide for automatic enrollment into the Plan and matching contribution and annual employer contribution formulas that differ from those that apply to participants who joined the Plan before January 1, 2022. The Plan’s sponsor is AbbVie Ltd. The Plan is subject to the provisions of the Employee Retirement Income Security Act of 1974 (“ERISA”), as amended.

Empower Retirement serves as the recordkeeper of the Plan and Empower Trust Company, LLC (“Custodian”) serves as the custodian. Banco Popular de Puerto Rico serves as trustee (“Trustee”) of the Plan.

Contributions and Vesting

Contributions to the Plan are paid to the AbbVie Puerto Rico Savings Plan Trust (“Trust”). The Trust is administered by the Trustee, the Custodian, and an investment committee comprised of AbbVie employees (the “Committee”).

Eligible employees electing to participate may choose to make their contributions from either pre-tax earnings or after-tax earnings or both, subject to certain limitations. Participants who have attained age 50 before the end of the Plan year and who are making the maximum pre-tax contribution are eligible to make catch-up contributions. Participants’ pre-tax contributions are an elective deferral feature, which is a cash or deferred arrangement under the provisions of Section 1081.01(d) of the Puerto Rico Internal Revenue Code of 2011 (“Puerto Rico Code”), as amended. All the contributions are subject to certain limitations of the Puerto Rico Code. Participant contributions may be invested in any of the investment options offered by the Plan.

Employer matching contributions to the Plan are made each payroll period based on the participating employees’ eligible earnings. Catch-up contributions are not eligible for matching contributions. The amount of the employer matching contribution for participants not covered by ASP+ is determined by the Board of Directors of AbbVie Ltd. and for the year ended December 31, 2025, was 5% of the participant’s eligible earnings if the employee elected to contribute at least 2% to the Plan. For participants covered by ASP+, contributions are matched dollar for dollar up to 6% of the participant’s eligible earnings.

NOTE A - DESCRIPTION OF THE PLAN - Continued

Contributions and Vesting - Continued

In addition, ASP+ participants receive an annual employer contribution if the ASP+ participant is employed by the Company on the last day of the Plan year or separated from employment during the Plan year due to death or qualifying retirement. The annual employer contribution is equal to a percentage of eligible compensation based on each eligible ASP+ participant’s age plus years of credited service according to the following schedule:


Age + Years of Credited Service (whole years)	Contribution Percentage
Less than 30	2	%
30-39	3	%
40-49	4	%
50-59	5	%
60-69	6	%
70 or more	7	%

Employer contributions are invested according to the employee’s investment elections.

Participants are at all times fully vested in their own contributions and earnings thereon. Vesting in employer matching contributions is based on the following vesting schedule:


Years of Credited Service	Vesting Percentage
Less than 2 years	0	%
2 years or more	100	%

Vesting in the annual employer contribution for ASP+ participants is based on the following vesting schedule:


Years of Credited Service	Vested Percentage
Less than 1	0	%
1	20	%
2	40	%
3	60	%
4	80	%
5 or more	100	%

NOTE A - DESCRIPTION OF THE PLAN - Continued

Contributions and Vesting - Continued

Non-vested portions of employer contributions and earnings thereon are forfeited upon the earlier of (a) the date of distribution of the vested portion of the participant’s full balance or (b) the date on which the participant incurs five consecutive “break years” (i.e., a 12-consecutive month period of severance). Forfeitures are used to (1) restore any forfeitures of participants who are reemployed with the Company before incurring five consecutive break years, (2) fund corrective allocations or contributions and/or (3) reduce future employer contributions. In 2025, approximately $41,000 of forfeitures were used to reduce AbbVie’s employer contributions. As of December 31, 2025 and 2024, approximately $76,400 and $34,600, respectively, of forfeitures were available.

Distributions

Following retirement, termination or death, participants or their beneficiaries receive a distribution in cash, AbbVie common shares or direct rollovers, as applicable. Also, participants may elect to defer distribution to a future date, but, after termination of employment, distribution must be made or commence by the 1^st of April following the year the participant reaches age 73. When participants defer distributions, their account balance remains in the Plan, and they may continue to transfer funds among the Plan’s investment options. Prior to separation of service, participants are permitted to withdraw their rollover contributions and their after-tax contributions in shares or in cash, subject to certain limitations. In-service withdrawals are available in certain other circumstances as defined by the Plan. The Plan also permits hardship withdrawals for participants who meet the criteria outlined in the Plan document.

Administrative Expenses

Investment fees for mutual funds and collective trusts are charged against the net assets of the respective fund. All other expenses incident to the administration of the Plan and Trust are charged to the Trust, except to the extent the Company pays such expenses directly. Expenses paid by the Company are excluded from these financial statements. To the extent that any expense is specifically attributable to a participant’s account (including, but not limited to, a managed account service fee, loan fee, Qualified Domestic Relations Order review fee, brokerage fee, or check fee), such expense is charged to the account of the participant.

Participant Accounts

NOTE A - DESCRIPTION OF THE PLAN - Continued

Notes Receivable from Participants

Participants may borrow from their accounts a minimum of $500 up to a maximum equal to the lesser of $50,000 or 50% of their vested account balance, subject to the Puerto Rico Code limitations and restrictions and Plan rules, and may have one or two loans outstanding. The loans are secured by the balance in the participant’s account. Participants pay interest on such loans at the prime rate on the first business day of the month the loan is made. Loans must be repaid within five years unless the loan is used for the purchase of the primary residence of the employee, in which case the repayment period can be extended to a period of fifteen years. Repayment is generally made through periodic payroll deductions but a loan may be repaid in a lump sum at any time. For employees terminating employment with the Company during the repayment period who do not repay their loan before distribution of their Plan account, the balance of the outstanding loan is netted from their Plan distribution.

DESCRIPTION OF THE PLAN (Tables)

12 Months Ended

Dec. 31, 2025

Schedule of the annual employer contribution in ASP+


Age + Years of Credited Service (whole years)	Contribution Percentage
Less than 30	2	%
30-39	3	%
40-49	4	%
50-59	5	%
60-69	6	%
70 or more	7	%

Schedule of the vesting


	Vesting
Years of Credited Service	Percentage
Less than 2 years	0	%
2 years or more	100	%


	Vested
Years of Credited Service	Percentage
Less than 1	0	%
1	20	%
2	40	%
3	60	%
4	80	%
5 or more	100	%

Schedule of the annual employer contribution in ASP+


Age + Years of Credited Service (whole years)	Contribution Percentage
Less than 30	2	%
30-39	3	%
40-49	4	%
50-59	5	%
60-69	6	%
70 or more	7	%

Schedule of the vesting


Years of Credited Service	Vesting Percentage
Less than 2 years	0	%
2 years or more	100	%


Years of Credited Service	Vested Percentage
Less than 1	0	%
1	20	%
2	40	%
3	60	%
4	80	%
5 or more	100	%

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Investment Valuation (Details) - USD ($) $ in Thousands	Dec. 31, 2025	Dec. 31, 2024
AbbVie Savings Plan
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Assets at fair value	$ 15,718,310	$ 13,183,237
AbbVie Savings Plan \| Interest bearing cash
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Assets at fair value	25	93
AbbVie Savings Plan \| Common stock
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Assets at fair value	3,047,016	2,583,223
AbbVie Savings Plan \| Mutual funds
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Assets at fair value	5,288	3,255
AbbVie Savings Plan \| Collective trust funds
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Assets at fair value	12,461,950	10,447,456
AbbVie Savings Plan \| Self-directed brokerage accounts
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Assets at fair value	204,031	149,210
AbbVie Savings Plan \| Level 1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Assets at fair value	15,718,310	13,183,237
AbbVie Savings Plan \| Level 1 \| Interest bearing cash
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Assets at fair value	25	93
AbbVie Savings Plan \| Level 1 \| Common stock
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Assets at fair value	3,047,016	2,583,223
AbbVie Savings Plan \| Level 1 \| Mutual funds
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Assets at fair value	5,288	3,255
AbbVie Savings Plan \| Level 1 \| Collective trust funds
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Assets at fair value	12,461,950	10,447,456
AbbVie Savings Plan \| Level 1 \| Self-directed brokerage accounts
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Assets at fair value	204,031	149,210
AbbVie Puerto Rico Savings Plan
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Assets at fair value	665,280	552,504
AbbVie Puerto Rico Savings Plan \| Common stock
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Assets at fair value	329,280	276,713
AbbVie Puerto Rico Savings Plan \| Mutual funds
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Assets at fair value	8,595	41,065
AbbVie Puerto Rico Savings Plan \| Collective trust funds
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Assets at fair value	325,555	233,155
AbbVie Puerto Rico Savings Plan \| Self-directed brokerage accounts
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Assets at fair value	1,850	1,571
AbbVie Puerto Rico Savings Plan \| Level 1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Assets at fair value	665,280	552,504
AbbVie Puerto Rico Savings Plan \| Level 1 \| Common stock
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Assets at fair value	329,280	276,713
AbbVie Puerto Rico Savings Plan \| Level 1 \| Mutual funds
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Assets at fair value	8,595	41,065
AbbVie Puerto Rico Savings Plan \| Level 1 \| Collective trust funds
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Assets at fair value	325,555	233,155
AbbVie Puerto Rico Savings Plan \| Level 1 \| Self-directed brokerage accounts
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Assets at fair value	$ 1,850	$ 1,571

SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)

12 Months Ended

Dec. 31, 2025

SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)

SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)

AbbVie Savings Plan

EIN: 320375147, Plan Number: 001

SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)

December 31, 2025

(Dollars in thousands)


Identity of party involved/		Current
description of asset/ rate/ maturity	Cost (a)	value
*AbbVie Inc., common stock		$	2,659,216

Abbott Laboratories, common stock			387,800

Interest bearing cash			25

Money market fund
Vanguard Federal Money Market			5,288

Collective trust funds
Capital Group EuroPacific Growth Trust, Class U2			353,033
Capital Group Growth Fund of America, Class U4			1,225,666
Capital Group Washington Mutual Investors Trust, Class U3			493,597
FIAM Core Plus Collective Investment Trust Class U			402,607
Galliard Stable Return Fund W			353,966
Galliard Managed Income Fund Core			100,810
State Street Target Retirement 2025 Securities Lending Series Fund Class IV			387,584
State Street Target Retirement 2030 Securities Lending Series Fund Class IV			674,828
State Street Target Retirement 2035 Securities Lending Series Fund Class IV			795,215
State Street Target Retirement 2040 Securities Lending Series Fund Class IV			829,694
State Street Target Retirement 2045 Securities Lending Series Fund Class IV			695,552
State Street Target Retirement 2050 Securities Lending Series Fund Class IV			516,905
State Street Target Retirement 2055 Securities Lending Series Fund Class IV			331,540
State Street Target Retirement 2060 Securities Lending Series Fund Class IV			191,110
State Street Target Retirement 2065 Securities Lending Series Fund Class IV			72,978
State Street Target Retirement 2070 Securities Lending Series Fund Class IV			4,496
State Street Target Retirement Income Securities Lending Series Fund Class IV			233,279
State Street Global Allcap Equity Ex-US Index Securities Lending Series Fund Class X			759,598
State Street S&P 500 Index Securities Lending Series Fund Class X			2,707,096
State Street US Bond Index Securities Lending Series Fund Class X			286,229
State Street US Extended Market Index Securities Lending Series Fund Class X			809,291
Wellington CIF II SMID Cap Research Class S5			236,876

Self-directed brokerage accounts			204,031

*Loans to participants, 3.25% to 9.50%			81,721

		$	15,800,031

*Represents a party-in-interest transaction.

(a) Cost information omitted as all investments are fully participant directed.

SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)

SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)

AbbVie Puerto Rico Savings Plan

EIN: 980429860, Plan Number: 002

SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)

December 31, 2025

(Dollars in thousands)


Identity of party involved/		Current
description of asset	Cost (a)	value

*AbbVie Inc., common stock		$	280,765

Abbott Laboratories, common stock			48,515

Money market fund
Vanguard Federal Money Market Fund			80

Mutual funds
American Funds EuroPacific Growth Fund, Class R6			8,515

Collective trust fund
Capital Group Growth Fund of America Class U4			31,418
Capital Group Washington Mutual Investment Trust Class U3			8,946
FIAM Core Plus Collective Investment Trust Class U			15,715
State Street Target Retirement 2025 Securities Lending Series Fund Class IV			13,164
State Street Target Retirement 2030 Securities Lending Series Fund Class IV			16,807
State Street Target Retirement 2035 Securities Lending Series Fund Class IV			14,099
State Street Target Retirement 2040 Securities Lending Series Fund Class IV			10,892
State Street Target Retirement 2045 Securities Lending Series Fund Class IV			7,539
State Street Target Retirement 2050 Securities Lending Series Fund Class IV			4,398
State Street Target Retirement 2055 Securities Lending Series Fund Class IV			4,573
State Street Target Retirement 2060 Securities Lending Series Fund Class IV			3,673
State Street Target Retirement 2065 Securities Lending Series Fund Class IV			2,169
State Street Target Retirement 2070 Securities Lending Series Fund Class IV			321
State Street Target Retirement Income Securities Lending Series Fund Class IV			11,051
State Street Global Allcap Equity Ex-US Index Securities Lending Series Fund Class X			30,340
State Street S&P 500 Index Securities Lending Series Fund Class X			63,691
State Street US Bond Index Securities Lending Series Fund Class X			14,494
State Street US Extended Market Index Securities Lending Series Fund Class X			17,903
Wellington CIF II SMID Cap Research Class S5			3,348
Galliard Stable Return Fund X			51,014

Self-directed brokerage accounts			1,850

*Loans to participants, 3.25% to 8.50%			7,771

		$	673,051

*Represents a party-in-interest transaction.

(a) Cost information omitted as all investments are fully participant directed.

STATEMENT OF CHANGES IN NET ASSETS AVAILABLE FOR BENEFITS $ in Thousands	12 Months Ended
	Dec. 31, 2025 USD ($)
AbbVie Savings Plan
Contributions
Employer	$ 384,684
Participant	468,482
Rollovers	82,234
Total contributions	935,400
Investment income
Net appreciation in fair value of investments	2,556,605
Interest and dividends	87,928
Net investment income	2,644,533
Interest income on notes receivable from participants	5,509
Total additions	3,585,442
Deductions
Benefits paid to participants	1,123,737
Other expenses	4,640
Total deductions	1,128,377
Net increase prior to transfers	2,457,065
Transfers to the Plan	107,054
NET INCREASE	2,564,119
Net assets available for benefits, Beginning of year	13,387,810
Net assets available for benefits, End of year	15,951,929
AbbVie Puerto Rico Savings Plan
Contributions
Employer	491
Participant	12,955
Rollovers	7,547
Total contributions	20,993
Investment income
Net appreciation in fair value of investments	114,351
Interest and dividends	10,745
Net investment income	125,096
Interest income on notes receivable from participants	510
Total additions	146,599
Deductions
Benefits paid to participants	31,513
Other expenses	394
Total deductions	31,907
NET INCREASE	114,692
Net assets available for benefits, Beginning of year	560,135
Net assets available for benefits, End of year	$ 674,827

SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR) (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2025 USD ($)
AbbVie Savings Plan
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Entity tax identification number	32-0375147
Plan number	001
Loans to participants	$ 81,721
Total	$ 15,800,031
AbbVie Savings Plan \| Investment, Identifier [Axis]: Abbott Laboratories, Common Stock
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:AbbottLaboratoriesMember
Investment current value type	AbbVie common shares
Current Value	$ 387,800
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Savings Plan \| Investment, Identifier [Axis]: Abbvie Inc., Common Stock
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:AbbvieIncMember
Investment current value type	AbbVie common shares
Current Value	$ 2,659,216
Asset held for investment, party-in-interest	true
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Savings Plan \| Investment, Identifier [Axis]: Capital Group Europacific Growth Trust, Class U2, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:CapitalGroupEuropacificGrowthTrustClassU2Member
Investment current value type	Collective trust funds
Current Value	$ 353,033
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Savings Plan \| Investment, Identifier [Axis]: Capital Group Growth Fund Of America, Class U4, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:CapitalGroupGrowthFundOfAmericaClassU4Member
Investment current value type	Collective trust funds
Current Value	$ 1,225,666
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Savings Plan \| Investment, Identifier [Axis]: Capital Group Washington Mutual Investors Trust, Class U3, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:CapitalGroupWashingtonMutualInvestorsTrustClassU3Member
Investment current value type	Collective trust funds
Current Value	$ 493,597
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Savings Plan \| Investment, Identifier [Axis]: Fiam Core Plus Collective Investment Trust Class U, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:FiamCorePlusCollectiveInvestmentTrustClassUMember
Investment current value type	Collective trust funds
Current Value	$ 402,607
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Savings Plan \| Investment, Identifier [Axis]: Galliard Managed Income Fund Core, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:GalliardManagedIncomeFundCoreMember
Investment current value type	Collective trust funds
Current Value	$ 100,810
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Savings Plan \| Investment, Identifier [Axis]: Galliard Stable Return Fund W, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:GalliardStableReturnFundWMember
Investment current value type	Collective trust funds
Current Value	$ 353,966
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Savings Plan \| Investment, Identifier [Axis]: State Street Global Allcap Equity Ex-Us Index Securities Lending Series Fund Class X, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:StateStreetGlobalAllcapEquityExUsIndexSecuritiesLendingSeriesFundClassXMember
Investment current value type	Collective trust funds
Current Value	$ 759,598
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Savings Plan \| Investment, Identifier [Axis]: State Street S&P 500 Index Securities Lending Series Fund Class X, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:StateStreetSP500IndexSecuritiesLendingSeriesFundClassXMember
Investment current value type	Collective trust funds
Current Value	$ 2,707,096
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Savings Plan \| Investment, Identifier [Axis]: State Street Target Retirement 2025 Securities Lending Series Fund Class Iv, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:StateStreetTargetRetirement2025SecuritiesLendingSeriesFundClassIvMember
Investment current value type	Collective trust funds
Current Value	$ 387,584
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Savings Plan \| Investment, Identifier [Axis]: State Street Target Retirement 2030 Securities Lending Series Fund Class Iv, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:StateStreetTargetRetirement2030SecuritiesLendingSeriesFundClassIvMember
Investment current value type	Collective trust funds
Current Value	$ 674,828
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Savings Plan \| Investment, Identifier [Axis]: State Street Target Retirement 2035 Securities Lending Series Fund Class Iv, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:StateStreetTargetRetirement2035SecuritiesLendingSeriesFundClassIvMember
Investment current value type	Collective trust funds
Current Value	$ 795,215
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Savings Plan \| Investment, Identifier [Axis]: State Street Target Retirement 2040 Securities Lending Series Fund Class Iv, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:StateStreetTargetRetirement2040SecuritiesLendingSeriesFundClassIvMember
Investment current value type	Collective trust funds
Current Value	$ 829,694
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Savings Plan \| Investment, Identifier [Axis]: State Street Target Retirement 2045 Securities Lending Series Fund Class Iv, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:StateStreetTargetRetirement2045SecuritiesLendingSeriesFundClassIvMember
Investment current value type	Collective trust funds
Current Value	$ 695,552
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Savings Plan \| Investment, Identifier [Axis]: State Street Target Retirement 2050 Securities Lending Series Fund Class Iv, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:StateStreetTargetRetirement2050SecuritiesLendingSeriesFundClassIvMember
Investment current value type	Collective trust funds
Current Value	$ 516,905
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Savings Plan \| Investment, Identifier [Axis]: State Street Target Retirement 2055 Securities Lending Series Fund Class Iv, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:StateStreetTargetRetirement2055SecuritiesLendingSeriesFundClassIvMember
Investment current value type	Collective trust funds
Current Value	$ 331,540
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Savings Plan \| Investment, Identifier [Axis]: State Street Target Retirement 2060 Securities Lending Series Fund Class Iv, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:StateStreetTargetRetirement2060SecuritiesLendingSeriesFundClassIvMember
Investment current value type	Collective trust funds
Current Value	$ 191,110
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Savings Plan \| Investment, Identifier [Axis]: State Street Target Retirement 2065 Securities Lending Series Fund Class Iv, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:StateStreetTargetRetirement2065SecuritiesLendingSeriesFundClassIvMember
Investment current value type	Collective trust funds
Current Value	$ 72,978
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Savings Plan \| Investment, Identifier [Axis]: State Street Target Retirement 2070 Securities Lending Series Fund Class Iv, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:StateStreetTargetRetirement2070SecuritiesLendingSeriesFundClassIvMember
Investment current value type	Collective trust funds
Current Value	$ 4,496
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Savings Plan \| Investment, Identifier [Axis]: State Street Target Retirement Income Securities Lending Series Fund Class Iv, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:StateStreetTargetRetirementIncomeSecuritiesLendingSeriesFundClassIvMember
Investment current value type	Collective trust funds
Current Value	$ 233,279
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Savings Plan \| Investment, Identifier [Axis]: State Street Us Bond Index Securities Lending Series Fund Class X, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:StateStreetUsBondIndexSecuritiesLendingSeriesFundClassXMember
Investment current value type	Collective trust funds
Current Value	$ 286,229
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Savings Plan \| Investment, Identifier [Axis]: State Street Us Extended Market Index Securities Lending Series Fund Class X, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:StateStreetUsExtendedMarketIndexSecuritiesLendingSeriesFundClassXMember
Investment current value type	Collective trust funds
Current Value	$ 809,291
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Savings Plan \| Investment, Identifier [Axis]: Vanguard Federal Money Market, Money Market Fund
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:VanguardFederalMoneyMarketMember
Investment current value type	us-gaap:MoneyMarketFundsMember
Current Value	$ 5,288
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Savings Plan \| Investment, Identifier [Axis]: Wellington Cif Ii Smid Cap Research Class S5, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:WellingtonCifIiSmidCapResearchClassS5Member
Investment current value type	Collective trust funds
Current Value	$ 236,876
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Savings Plan \| Interest bearing cash
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Current Value	$ 25
AbbVie Savings Plan \| Self-directed brokerage accounts
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Current Value	$ 204,031
AbbVie Savings Plan \| Minimum
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Interest rates of Loans to participants	3.25%
AbbVie Savings Plan \| Maximum
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Interest rates of Loans to participants	9.50%
AbbVie Puerto Rico Savings Plan
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Entity tax identification number	98-0429860
Plan number	002
Loans to participants	$ 7,771
Total	$ 673,051
AbbVie Puerto Rico Savings Plan \| Investment, Identifier [Axis]: Abbott Laboratories, Common Stock
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:AbbottLaboratoriesMember
Investment current value type	AbbVie common shares
Current Value	$ 48,515
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Puerto Rico Savings Plan \| Investment, Identifier [Axis]: Abbvie Inc., Common Stock
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:AbbvieIncMember
Investment current value type	AbbVie common shares
Current Value	$ 280,765
Asset held for investment, party-in-interest	true
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Puerto Rico Savings Plan \| Investment, Identifier [Axis]: American Funds Europacific Growth Fund, Class R6, Mutual Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:AmericanFundsEuropacificGrowthFundClassR6Member
Investment current value type	Mutual funds
Current Value	$ 8,515
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Puerto Rico Savings Plan \| Investment, Identifier [Axis]: Capital Group Growth Fund Of America, Class U4, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:CapitalGroupGrowthFundOfAmericaClassU4Member
Investment current value type	Collective trust funds
Current Value	$ 31,418
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Puerto Rico Savings Plan \| Investment, Identifier [Axis]: Capital Group Washington Mutual Investment Trust Class U3, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:CapitalGroupWashingtonMutualInvestmentTrustClassU3Member
Investment current value type	Collective trust funds
Current Value	$ 8,946
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Puerto Rico Savings Plan \| Investment, Identifier [Axis]: Fiam Core Plus Collective Investment Trust Class U, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:FiamCorePlusCollectiveInvestmentTrustClassUMember
Investment current value type	Collective trust funds
Current Value	$ 15,715
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Puerto Rico Savings Plan \| Investment, Identifier [Axis]: Galliard Stable Return Fund W, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:GalliardStableReturnFundXMember
Investment current value type	Collective trust funds
Current Value	$ 51,014
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Puerto Rico Savings Plan \| Investment, Identifier [Axis]: State Street Global Allcap Equity Ex-Us Index Securities Lending Series Fund Class X, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:StateStreetGlobalAllcapEquityExUsIndexSecuritiesLendingSeriesFundClassXMember
Investment current value type	Collective trust funds
Current Value	$ 30,340
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Puerto Rico Savings Plan \| Investment, Identifier [Axis]: State Street S&P 500 Index Securities Lending Series Fund Class X, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:StateStreetSP500IndexSecuritiesLendingSeriesFundClassXMember
Investment current value type	Collective trust funds
Current Value	$ 63,691
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Puerto Rico Savings Plan \| Investment, Identifier [Axis]: State Street Target Retirement 2025 Securities Lending Series Fund Class Iv, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:StateStreetTargetRetirement2025SecuritiesLendingSeriesFundClassIvMember
Investment current value type	Collective trust funds
Current Value	$ 13,164
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Puerto Rico Savings Plan \| Investment, Identifier [Axis]: State Street Target Retirement 2030 Securities Lending Series Fund Class Iv, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:StateStreetTargetRetirement2030SecuritiesLendingSeriesFundClassIvMember
Investment current value type	Collective trust funds
Current Value	$ 16,807
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Puerto Rico Savings Plan \| Investment, Identifier [Axis]: State Street Target Retirement 2035 Securities Lending Series Fund Class Iv, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:StateStreetTargetRetirement2035SecuritiesLendingSeriesFundClassIvMember
Investment current value type	Collective trust funds
Current Value	$ 14,099
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Puerto Rico Savings Plan \| Investment, Identifier [Axis]: State Street Target Retirement 2040 Securities Lending Series Fund Class Iv, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:StateStreetTargetRetirement2040SecuritiesLendingSeriesFundClassIvMember
Investment current value type	Collective trust funds
Current Value	$ 10,892
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Puerto Rico Savings Plan \| Investment, Identifier [Axis]: State Street Target Retirement 2045 Securities Lending Series Fund Class Iv, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:StateStreetTargetRetirement2045SecuritiesLendingSeriesFundClassIvMember
Investment current value type	Collective trust funds
Current Value	$ 7,539
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Puerto Rico Savings Plan \| Investment, Identifier [Axis]: State Street Target Retirement 2050 Securities Lending Series Fund Class Iv, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:StateStreetTargetRetirement2050SecuritiesLendingSeriesFundClassIvMember
Investment current value type	Collective trust funds
Current Value	$ 4,398
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Puerto Rico Savings Plan \| Investment, Identifier [Axis]: State Street Target Retirement 2055 Securities Lending Series Fund Class Iv, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:StateStreetTargetRetirement2055SecuritiesLendingSeriesFundClassIvMember
Investment current value type	Collective trust funds
Current Value	$ 4,573
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Puerto Rico Savings Plan \| Investment, Identifier [Axis]: State Street Target Retirement 2060 Securities Lending Series Fund Class Iv, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:StateStreetTargetRetirement2060SecuritiesLendingSeriesFundClassIvMember
Investment current value type	Collective trust funds
Current Value	$ 3,673
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Puerto Rico Savings Plan \| Investment, Identifier [Axis]: State Street Target Retirement 2065 Securities Lending Series Fund Class Iv, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:StateStreetTargetRetirement2065SecuritiesLendingSeriesFundClassIvMember
Investment current value type	Collective trust funds
Current Value	$ 2,169
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Puerto Rico Savings Plan \| Investment, Identifier [Axis]: State Street Target Retirement 2070 Securities Lending Series Fund Class Iv, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:StateStreetTargetRetirement2070SecuritiesLendingSeriesFundClassIvMember
Investment current value type	Collective trust funds
Current Value	$ 321
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Puerto Rico Savings Plan \| Investment, Identifier [Axis]: State Street Target Retirement Income Securities Lending Series Fund Class Iv, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:StateStreetTargetRetirementIncomeSecuritiesLendingSeriesFundClassIvMember
Investment current value type	Collective trust funds
Current Value	$ 11,051
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Puerto Rico Savings Plan \| Investment, Identifier [Axis]: State Street Us Bond Index Securities Lending Series Fund Class X, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:StateStreetUsBondIndexSecuritiesLendingSeriesFundClassXMember
Investment current value type	Collective trust funds
Current Value	$ 14,494
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Puerto Rico Savings Plan \| Investment, Identifier [Axis]: State Street Us Extended Market Index Securities Lending Series Fund Class X, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:StateStreetUsExtendedMarketIndexSecuritiesLendingSeriesFundClassXMember
Investment current value type	Collective trust funds
Current Value	$ 17,903
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Puerto Rico Savings Plan \| Investment, Identifier [Axis]: Vanguard Federal Money Market, Money Market Fund
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:VanguardFederalMoneyMarketMember
Investment current value type	us-gaap:MoneyMarketFundsMember
Current Value	$ 80
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Puerto Rico Savings Plan \| Investment, Identifier [Axis]: Wellington Cif Ii Smid Cap Research Class S5, Collective Trust Funds
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Investment issuer name	abbv:WellingtonCifIiSmidCapResearchClassS5Member
Investment current value type	Collective trust funds
Current Value	$ 3,348
Participation status	us-gaap-ebp:EmployeeBenefitPlanParticipantDirectedMember
AbbVie Puerto Rico Savings Plan \| Self-directed brokerage accounts
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Current Value	$ 1,850
AbbVie Puerto Rico Savings Plan \| Minimum
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Interest rates of Loans to participants	3.25%
AbbVie Puerto Rico Savings Plan \| Maximum
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
Interest rates of Loans to participants	8.50%

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

12 Months Ended

Dec. 31, 2025

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Accounting

The financial statements have been prepared using the accrual basis of accounting.

Use of Estimates

NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued

Investment Valuation

Interest bearing cash - Valued at its holding amount.

Common stock, mutual funds and collective trust funds - Valued at the published net asset value (“NAV”) or market price per share.

The fair value hierarchy under the accounting standard for fair value measurements consists of the following three levels:

●

Level 1 – Valuations based on unadjusted quoted prices in active markets for identical assets that the Plan has the ability to access;

●

The following tables set forth the fair value hierarchy levels of the Plan’s assets at fair value at December 31, (dollars in thousands):


	Basis of Fair Value Measurement
2025	Level 1		Level 2		Level 3		Total
Interest bearing cash	$	25	$	—	$	—	$	25
Common stock		3,047,016		—		—		3,047,016
Mutual funds		5,288		—		—		5,288
Collective trust funds		12,461,950		—		—		12,461,950
Self-directed brokerage accounts		204,031		—		—		204,031
Total assets at fair value	$	15,718,310	$	—	$	—	$	15,718,310


	Basis of Fair Value Measurement
2024	Level 1		Level 2		Level 3		Total
Interest bearing cash	$	93	$	—	$	—	$	93
Common stock		2,583,223		—		—		2,583,223
Mutual funds		3,255		—		—		3,255
Collective trust funds		10,447,456		—		—		10,447,456
Self-directed brokerage accounts		149,210		—		—		149,210
Total assets at fair value	$	13,183,237	$	—	$	—	$	13,183,237

NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued

Notes Receivable from Participants

Investment Income Recognition

Payment of Benefits

Benefits are recorded when paid.